Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to:


Good News Update
Week of September 28, 2015
Mandatory Annual Compliance Seminar on Wednesday, October 7
Brian Bates, CPA, and Stephen Stair, MD, present "Big Data. Rise of the Machines"
Faculty Development for Educators
Apply to advanced degree or immersion programs.
Renal Insufficiency in Cirrhosis
Ashwani Singal, MD, MS
September 2015 Research Spotlight
Employee of the Month Priscilla Smith
SAV Tolwani FPTW